Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies

Year
2019
Type(s)
Authors
Netanel Tzarum, Erick Giang, Leopold Kong, Linling He, Jannick Prentoe, Elias Augestad, Yuanzi Hua, Shaun Castillo, Georg M. Lauer, Jens Bukh, Jiang Zhu, Ian A. Wilson and Mansun Law
Source
Science Advances 02Jan 2019:eaav1882
Url
http://advances.sciencemag.org/content/5/1/eaav1882
Bibtext
BibTeX
https://doi.org/10.1126/sciadv.aav1882
Published By: American Association for the Advancement of Science
Online ISSN: 2375-2548

Abstract:

An effective vaccine to the antigenically diverse hepatitis C virus (HCV) must target conserved immune epitopes. Here, we investigate cross-neutralization of HCV genotypes by broadly neutralizing antibodies (bNAbs) encoded by the relatively abundant human gene family VH1-69. We have deciphered the molecular requirements for cross-neutralization by this unique class of human antibodies from crystal structures of HCV E2 in complex with bNAbs. An unusually high binding affinity is found for germ line–reverted versions of VH1-69 precursor antibodies, and neutralization breadth is acquired during affinity maturation. Deep sequencing analysis of an HCV-immune B cell repertoire further demonstrates the importance of the VH1-69 gene family in the generation of HCV bNAbs. This study therefore provides critical insights into immune recognition of HCV with important implications for rational vaccine design.